z-logo
open-access-imgOpen Access
Causes of resistance to PARP inhibitors and ways to overcome it. Case report of aggressive <i>BRCA</i>-related breast cancer
Author(s) -
А. I. Stukan,
A. Yu. Goryainova,
С. В. Шаров,
O. A. Goncharova,
Z. K. Khachmamuk,
V. V. Durov
Publication year - 2022
Publication title -
opuholi ženskoj reproduktivnoj sistemy
Language(s) - English
Resource type - Journals
eISSN - 1999-8627
pISSN - 1994-4098
DOI - 10.17650/1994-4098-2022-18-1-54-65
Subject(s) - olaparib , breast cancer , parp inhibitor , medicine , poly adp ribose polymerase , veliparib , disease , cancer , cancer research , liquid biopsy , oncology , bioinformatics , biology , gene , genetics , polymerase

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here